Monthly Archives: January 2017

TCPA survives strict scrutiny

Brickman v. Facebook, Inc., No. 16-cv-00751, 2017 BL 25487 (N.D. Cal. Jan. 27, 2017) One criticism of expanding strict scrutiny is that courts will be extremely tempted to find that sensible regulations pass strict scrutiny, thus watering down its protection … Continue reading

Advertisement

Posted in Uncategorized | Tagged , | Leave a comment

Amazon escapes liability for ads & emails touting vendors’ infringing products

Lasoff v. Amazon.com Inc, 2017 WL 372948, No. C16-151 (W.D. Wash. Jan. 26, 2017) Lasoff owns Ingrass, which sells artificial turf and related products.  He sold through Amazon, but in 2013 his sales allegedly began to plummet, both on his … Continue reading

Posted in Uncategorized | Tagged , , , | Leave a comment

Disgorgement isn’t distinguishable from restitution in ordinary consumer protection case

Brazil v. Dole Packaged Foods, LLC, 660 Fed.Appx. 531 (9th Cir. 2016) Brazil brought the usual California claims, alleging that defendants deceptively described their fruit products as “All Natural Fruit.” Brazil property alleged that Dole’s labels were deceptive given that … Continue reading

Posted in Uncategorized | Tagged , , , , | Leave a comment

For law students: Notre Dame summer IP program

Details on the Notre Dame “Get a Leg Up in IP” program this summer. from Blogger http://ift.tt/2jRCLXK

Posted in Uncategorized | Tagged | Leave a comment

Another “omissions about slave labor” case fails in Cal.

Sud v. Costco Wholesale Corp., No. 15-cv-03783, 2017 WL 345994 (N.D. Cal. Jan. 24, 2017) Sud brought the usual California claims based on allegations that Costco sold prawns for which the supply chain was tainted by slavery, human trafficking, and … Continue reading

Posted in Uncategorized | Tagged , , , | Leave a comment

Older case: placement of medical device on market isn’t representation of FDA approval

Intra-Lock International, Inc. v. Choukroun, 2015 WL 11422285, No. 14-cv-80930 (S.D. Fla. May 4, 2015) Old, but new in Westclip (why? It’s an algorithmic mystery), and presents an interesting fact pattern about FDA approval/the lack thereof and the relationship between … Continue reading

Posted in Uncategorized | Tagged , | Leave a comment

False claims of discounts cause Article III injury

Morrow v. Ann Inc., 2017 WL 363001, No. 16-CV-3340 (S.D.N.Y. Jan. 24, 2017) Plaintiffs alleged that Ann deceptively advertised merchandise sold in its Ann Taylor Factory and LOFT Outlet stores by falsely claiming on its sales tags, in-store signage, and … Continue reading

Posted in Uncategorized | Tagged , | Leave a comment

Placebo effect means customer satisfaction doesn’t disprove harm; suggestive TM can be fact claim

In re 5-hour ENERGY Marketing & Sales Practices Litig., No. MDL 13-2438, 2017 WL 385042 (C.D. Cal. Jan. 24, 2017) Plaintiffs alleged that defendants engaged in deceptive and unfair business practices under the laws of various states and the Magnuson-Moss … Continue reading

Posted in Uncategorized | Tagged , , | Leave a comment

Food & Drug Law Institute writing competition

Thomas Austern Writing Competition:   The H. Thomas Austern Writing Competition is intended to encourage law student interest in the areas of law that affect food, drugs, biologics, cosmetics, dietary supplements, medical devices, and tobacco. Top papers will be considered for publication … Continue reading

Posted in Uncategorized | Tagged | Leave a comment

Identifying Boundaries in Patent and Trademark Law.

The American University Law Review is proud to present its annual Federal Circuit symposium,  Panel 2: Trademarks First Amendment Freedom of Speech and Trademarks: What Is, and What Should Be, the Relationship Between the Two? Christine Farley, American University Washington … Continue reading

Posted in Uncategorized | Tagged , , , | Leave a comment